Clinical Trial: MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Melanoma (Skin)
Study Type: INTERVENTIONAL
Official Title: A Phase I/IIa, First-In-Human, Multi-Center Dose Escalation and Dose Expansion Study of [203/212Pb]VMT01 Receptor-Targeted, Image-Guided Alpha-Particle Therapy in Patients With Previously Tr
Brief Summary:
In this first-in human, phase I/IIa study, the safety and efficacy of [212Pb]VMT01, an alpha-particle emitting therapeutic agent targeted to melanocortin sub-type 1 receptor (MC1R) is being evaluated in patients with unresectable and metastatic melanoma.
Read more